Urachus cancer is a rare cancer that starts in a small leftover tissue between the bladder and belly button. Early symptoms of urachus cancer can include blood in the urine, belly or pelvic pain, and repeated urinary infections, but some people have no clear warning signs at first. It usually affects adults, often in midlife or later, and many living with urachus cancer need care over months to years depending on the stage. Not everyone will have the same experience. Treatment often includes surgery and may also include chemotherapy, and the outlook for urachus cancer varies because advanced disease can be life-threatening.
How many people live with Urachus cancer?
There is no single registry count for how many people are living with urachus cancer, but the often-cited estimate of about 1 in 5 million people suggests roughly 1,600 people worldwide (National Organization for Rare Disorders, 2023). Using that same estimate, about 70 people may be living with it in the United States (National Organization for Rare Disorders, 2023).
Overview
Urachus cancerSymptoms
Urachus cancer often causes blood in the urine. Some people also notice belly pain, frequent urinary infections, or mucus in the urine. Early symptoms of urachus cancer can be mild, so it may go unnoticed at first.
Outlook and prognosis
Outlook for urachus cancer depends mainly on stage and whether surgery removes all visible cancer. Many living with urachus cancer do best when it is found early and still limited to the bladder area. Follow-up matters because recurrence can happen.
Causes and risk factors
The exact cause of urachus cancer is often unclear. Risk may be higher in people born with leftover urachal tissue, especially if it stays irritated or infected over time. It is also seen more often in adults, particularly men.
Genetic influences
Genetics do not appear to drive most urachus cancer cases strongly. In urachus cancer, inherited risk is not well established, but tumor gene changes can sometimes help guide testing, outlook, or treatment decisions.
Diagnosis
Diagnosis of urachus cancer usually starts with symptoms and imaging, often a CT scan. Doctors confirm urachus cancer with cystoscopy and a biopsy, checking tissue under a microscope.
Treatment and drugs
Treatment for urachus cancer usually involves surgery to remove the tumor, often along with part of the bladder and the urachus. Depending on the stage, some people also need chemotherapy, and care is usually guided by a urologic cancer team.
Symptoms
Urachus cancer often shows up as changes in urination or discomfort low in the abdomen, and some people feel well at first. The changes are often subtle at first, blending into daily life until they become more noticeable. Blood in the urine is the most common warning sign, but mucus in the urine, repeated urinary infections, belly button changes, or a lower abdominal lump can also happen. Because early symptoms of urachus cancer can overlap with more common urinary problems, medical evaluation matters.
This may turn urine pink, red, or brown, or it may only show up on a lab test. It is the most common symptom of urachus cancer and should always be checked, even if it happens just once.
Some people notice cloudy, stringy, or jelly-like material when they urinate. This can happen because urachus tumors often produce mucus, although other bladder and urinary problems can cause similar changes too.
Ache, pressure, or tenderness below the belly button can develop as the tumor grows. For many, this can mean discomfort when bending, coughing, or when the bladder feels full.
Needing to urinate more often, feeling pressure, or having burning with urination can happen if the area near the bladder is irritated. Some may find these symptoms come and go, which can make them easy to mistake for a routine urinary issue.
How people usually first notice Urachus cancer?
Urachus cancer is often first noticed quietly, with blood in the urine being the symptom that most often gets attention because it can be alarming even when it is painless. Some people also notice mucus in the urine, repeated urinary tract infections, lower belly pain, or a feeling of pressure around the bladder, while others are found to have it after tests for urinary problems that do not go away. Because early signs can be vague and easy to mistake for more common bladder issues, the first signs of urachus cancer are sometimes picked up only after imaging, cystoscopy, or urine testing ordered for persistent symptoms.
Types of Urachus cancer
Urachus cancer is rare, and the different types of urachus cancer are usually based on how the tumor cells look under a microscope. These variants can behave a little differently, but many living with urachus cancer notice similar early symptoms, such as blood in the urine, lower belly discomfort, or mucus in the urine. Symptoms don’t always look the same for everyone.
Adenocarcinoma
This is by far the most common type of urachus cancer, and it starts in gland-like cells that can make mucus. Many people have blood in the urine or mucus in the urine, while some also notice pressure or pain low in the belly.
Mucinous type
This form makes large amounts of mucus, which can sometimes show up in the urine or collect around the tumor. For many, this can mean urinary symptoms that seem unusual at first, such as cloudy urine, mucus strands, or ongoing bladder irritation.
Enteric type
This variant looks somewhat like cells normally seen in the intestine, even though it grows in the urachus area. Symptoms are often much like other urachus cancers, but some may find belly pain or a palpable mass is more noticeable than urinary changes.
Signet ring type
This is a rare and often more aggressive variant in which the cells contain abundant mucus. People may notice the same early symptoms of urachus cancer, but problems can worsen faster if the tumor spreads beyond the bladder area.
Mixed type
Some tumors contain more than one cell pattern, so doctors describe them as mixed. The balance of symptoms can shift over time, depending on which part of the tumor is growing and whether it is affecting the bladder, nearby tissues, or both.
Can I slow down the onset of symptoms?
No clear evidence shows that lifestyle changes or medicines can meaningfully delay the start of symptoms in urachus cancer. Because this cancer is very rare, there are no well-established screening tests or preventive treatments for people who feel well, and while general healthy habits like not smoking are still good for overall health, they have not been shown to reduce the risk of or prevent this cancer. The most useful step is to get checked जल्दी if you notice blood in the urine, pain in the lower belly, or fluid from the belly button, since finding a problem earlier can help with care even though it may not stop it from starting.
What genetics can tell you about symptoms
For people living with urachus cancer, genetics usually cannot predict day-to-day symptoms in a clear or reliable way, because symptoms are driven more by where the tumor is, how large it is, and whether it has spread. Some genetic changes found in the cancer cells may be linked with how the disease behaves or how aggressive it seems, but they do not consistently tell doctors exactly which symptoms will appear, how severe they will be, or when they will start. In some cases, inherited gene changes may raise the risk of developing certain cancers, but urachus cancer is rare, and the genetic patterns behind symptoms are still not well defined.
Causes and risk factors
Urachus cancer usually starts in leftover tissue called a urachal remnant, which is present when a small channel near the bladder does not fully close before birth. The risk factors for urachus cancer are not well defined because this cancer is very rare. It is seen more often in adults in midlife or later, and it appears more common in men. Long-term irritation, infection, or other chronic inflammation in that leftover tissue may raise risk. Researchers are still learning how these pieces fit together, and no clear inherited gene change or lifestyle habit has been proven as a common cause.
What are the most common causes or risk factors?
The exact cause of urachus cancer is not known, but it usually starts in a small piece of tissue left over from before birth that connects the bladder to the belly button area. It is seen more often in adults, especially middle-aged or older adults, and in men, and long-term irritation, repeated infection, or other ongoing problems in that leftover tissue may raise the risk. Unlike some other cancers, there are no well-proven inherited gene changes or strong family risk factors linked to urachus cancer.
Environmental and biological risk factors
Urachus cancer is very rare, so its risk factors are not mapped out as clearly as they are for more common cancers. Most known risk factors for urachus cancer are biological rather than environmental, and some people develop it without any obvious trigger. Researchers are still exploring how outside influences interact with our inner biology.
A urachal remnant means a small piece of tissue from before birth stays between the bladder and belly button. Urachus cancer usually starts in this leftover tissue, so its presence is the main biological risk factor. Most people with a remnant never develop cancer, but it creates the tissue where the cancer can begin.
Repeated infection, inflammation, or long-term swelling in a urachal cyst or remnant may raise risk over time. Ongoing irritation can push cells to change in unhealthy ways, although the exact level of risk is still uncertain.
Urachus cancer is most often found in adults, especially around middle age. It is uncommon in children and younger adults, which suggests risk increases as people get older.
Men are diagnosed with urachus cancer more often than women. The reason is not fully understood, but sex appears to affect who is more likely to develop it.
Genetic risk factors
For urachus cancer, inherited genetic risk is still poorly understood because the disease is so rare. Researchers have not found a clear gene change passed down through families that explains most cases. Carrying a genetic change doesn't guarantee the condition will appear. Most DNA changes linked with urachus cancer are found in the tumor after it develops, not in the genes someone is born with.
No clear gene: No single inherited gene has been proven to cause most cases of urachus cancer. Many people with urachus cancer have no known family pattern that points to a specific passed-down risk.
Rare cancer limits: Because this cancer is so uncommon, researchers still have limited data on the genetic risk factors for urachus cancer. That makes inherited risk harder to measure than it is for more common cancers.
Tumor DNA changes: Studies have found changes in genes such as TP53, KRAS, APC, and SMAD4 in some urachus tumors. These are usually acquired changes inside the cancer cells, not inherited changes present from birth.
Family history clues: If several close relatives have colorectal, uterine, or other cancers at young ages, doctors may look for a broader hereditary cancer syndrome. Even so, a direct inherited link between those syndromes and urachus cancer has not been clearly proven.
Lifestyle risk factors
Urachus cancer is very rare, so its lifestyle-related risks are not as clearly defined as they are for more common cancers. Still, some modifiable habits may influence risk through effects on the urinary tract, chronic inflammation, and overall cancer biology. When people ask about lifestyle risk factors for urachus cancer, the strongest practical focus is on smoking and broader habits linked to metabolic health.
Tobacco use is the clearest lifestyle factor that may raise the risk of cancers involving the urinary tract. Harmful chemicals from smoke enter the bloodstream and are filtered into urine, which can expose the bladder area and nearby urachal tissue to carcinogens.
Obesity is linked to chronic low-grade inflammation, altered hormone signaling, and insulin resistance, all of which can support cancer development. Although direct evidence for urachus cancer is limited, maintaining a healthy weight may reduce these cancer-promoting pressures.
Low activity levels can worsen weight gain, metabolic dysfunction, and inflammation, which are factors associated with higher cancer risk overall. Regular exercise may help lower these effects and support healthier insulin and immune function.
Diets high in heavily processed foods and low in fiber-rich plant foods can contribute to obesity and poor metabolic health. While no specific diet is proven to cause urachus cancer, long-term eating patterns that promote inflammation may increase overall cancer vulnerability.
Risk prevention
There is no known, proven way to fully prevent urachus cancer, because it is a rare cancer and its exact causes are not well understood. For many living with concerns about urachus cancer, prevention is mainly about lowering avoidable cancer risks and getting possible warning signs checked early. Prevention is about lowering risk, not eliminating it completely. This matters because blood in the urine or repeated bladder-area symptoms can sometimes overlap with early symptoms of urachus cancer.
Avoiding tobacco may help lower the risk of bladder and urinary tract cancers, including cancers near the bladder such as urachus cancer. If you smoke, quitting now can still benefit your long-term health.
Blood in the urine should always be assessed, even if it happens only once or comes without pain. Early evaluation may help find urachus cancer or another urinary problem sooner.
Repeated urinary infections, mucus in the urine, lower belly pain, or pressure above the bladder should not be ignored. Getting persistent symptoms checked may reduce delays in diagnosing urachus cancer.
Routine care can help catch health changes that might otherwise be easy to dismiss during busy daily life. Prevention works best when combined with regular check-ups.
Can you prevent Urachus cancer?
There is no known, proven way to prevent urachus cancer, and in most cases it is not caused by anything you did. This rare cancer often starts in a small piece of tissue left over from before birth, so there are no clear lifestyle steps that are known to stop it from happening. Even though that is not prevention, getting checked promptly for blood in the urine, mucus in the urine, or fluid leaking from the belly button can help it be found earlier.
Transmission
Urachus cancer is not contagious, so it cannot be passed from one person to another through close contact, kissing, sex, coughing, or sharing food and bathrooms. For many living with Urachus cancer, this means there is no risk of “catching” it from someone else or giving it to family members or partners.
In most cases, Urachus cancer is also not inherited in a clear parent-to-child pattern. When people ask about how Urachus cancer is inherited, the answer is usually that it develops sporadically, often from leftover urachal tissue that has been present since before birth, rather than from a gene passed down through a family.
When to test your genes
For urachal cancer, inherited gene testing is not routine for most people because this cancer is usually not strongly linked to a known hereditary syndrome. It is most worth discussing if you were diagnosed unusually young, have several relatives with cancer, or have advanced or recurrent disease, where tumor gene profiling may help guide treatment.
Diagnosis
Urachus cancer is usually diagnosed after symptoms such as blood in the urine, repeated urinary infections, belly pain, or mucus in the urine lead to medical evaluation. Because this cancer is rare and can look like more common bladder problems at first, the diagnosis of urachus cancer often takes more than one test. Doctors usually begin by asking about symptoms and checking for other possible causes before moving on to imaging and tissue testing.
Your doctor will ask when symptoms started, how often they happen, and whether you have urinary bleeding, pain, or frequent infections. They will also review your past health and examine your abdomen to look for clues that point toward the bladder area.
Urine testing can check for blood, signs of infection, and other changes that may explain symptoms. These tests cannot confirm urachus cancer on their own, but they help guide the next steps and rule out common causes.
A CT scan of the abdomen and pelvis is one of the main tests used to look for a mass near the top of the bladder where the urachus sits. It can also show whether the cancer has grown into nearby tissues or spread farther.
MRI or ultrasound may be used to get a closer look at the area if the first imaging test leaves questions. These imaging findings can help show the size of the tumor and whether it appears connected to the bladder and urachus.
How is Urachus cancer diagnosed?
Urachus cancer is usually diagnosed with imaging tests such as an ultrasound or CT scan to look for a growth between the bladder and the belly button area, along with a bladder check using a thin camera and a small tissue sample to confirm that it is cancer. Doctors also pay close attention to where the growth started, because a tumor that begins near the top of the bladder in the urachus area can look different from other bladder cancers. Genetic testing is not usually needed to make the diagnosis, although the tumor tissue may sometimes be tested later to help guide treatment.
Stages of Urachus cancer
Urachus cancer is usually described in stages based on how far it has grown or spread. Because this is a rare cancer, doctors may use more than one staging system, but the overall idea is similar: earlier stages are more limited, and later stages have spread farther. Many people feel reassured knowing what their tests can—and can’t—show. When people ask about the stages of urachus cancer, they are usually asking whether it is still confined to the area near the bladder or has moved into nearby tissues, lymph nodes, or farther parts of the body.
Stage I
The cancer is limited to the urachus or the area where it started near the top of the bladder. It has not clearly spread into deeper nearby tissues or distant parts of the body.
Stage II
The cancer has grown into the bladder wall. At this stage, many living with urachus cancer still have disease centered in one area, which may make surgery a main treatment option.
Stage III
The cancer has spread into nearby tissues, such as the fat around the bladder, the lining inside the abdomen, nearby organs, or regional lymph nodes. For many, this means treatment planning becomes more complex and may involve more than one approach.
Stage IV
The cancer has spread to distant parts of the body, such as the lungs, liver, bones, or distant lymph nodes. Symptoms can vary more at this stage, depending on where the cancer has spread.
Outlook and prognosis
Outlook in urachus cancer depends mainly on the stage at diagnosis and whether the tumor can be completely removed, with localized disease having a substantially better prognosis than cancer that has spread to lymph nodes or distant organs. Because many cases are found late, recurrence after treatment is not uncommon, especially within the pelvis, bladder, or distant sites such as the lungs and liver. Reported 5-year overall survival rates vary widely across studies, but are often around 40% to 60% overall and can be much higher for early-stage, fully resected tumors. Advanced or metastatic urachus cancer generally carries a poorer prognosis, and long-term disease control is more difficult even with chemotherapy or other systemic treatment. Mortality is driven largely by stage, incomplete surgical resection, and recurrence, with survival significantly shorter once the disease is unresectable or metastatic. Close follow-up after treatment is important because early detection of recurrence may allow additional therapy.
Long-term effects
Urachus cancer can affect long-term health in very different ways depending on how early it is found, whether it has spread, and how much treatment is needed. For some, the main issues come from major surgery and ongoing follow-up; for others, the bigger concern is the risk that the cancer returns or spreads later. The long-term picture is often shaped by stage at diagnosis, because earlier-stage urachus cancer generally has a better outlook than cancer found after it has grown beyond the bladder area.
Urachus cancer can come back after treatment, sometimes months or years later. Because of this, doctors often recommend long-term scans, urine checks, and visits to watch for signs of recurrence.
If urachus cancer has spread, long-term effects can include ongoing symptoms from metastatic disease and the need for repeated treatment. Spread to nearby tissues or distant organs usually lowers the overall prognosis.
Surgery for urachus cancer often involves part of the bladder, which can lead to changes in bladder capacity or control. Some people notice they need to urinate more often, feel urgency, or have discomfort as they recover.
Major abdominal or pelvic surgery can leave lasting effects such as scar tissue, hernias, or bowel changes. For many, this can mean a slower return to normal routines, especially after extensive surgery.
How is it to live with Urachus cancer?
Living with urachus cancer often means coping with a rare and unsettling illness that can bring blood in the urine, belly or pelvic pain, fatigue, and the strain of scans, surgery, and sometimes chemotherapy. Daily life may revolve around medical appointments, recovery time, and managing energy, especially if treatment affects bladder function or causes discomfort with movement and routine activities. For the people around you, this can mean practical caregiving, emotional worry, and changes in family roles, but clear information, shared support, and a treatment plan can help many families regain a sense of control.
Treatment and drugs
Treatment for urachus cancer usually centers on surgery, because the main goal is to remove the tumor completely, often along with the urachus and part of the bladder. If the cancer has spread, or if surgery cannot remove all of it, doctors may use chemotherapy, though urachus cancer is rare and treatment plans are often tailored to the individual case rather than following one standard approach. Doctors sometimes recommend a combination of lifestyle changes and drugs, but for urachus cancer, medicines are mainly used to treat the cancer itself or help with symptoms such as pain, nausea, or urinary discomfort. Not every treatment works the same way for every person, and follow-up imaging and checkups are an important part of care because this cancer can come back after treatment. For many, this can mean working with a urologist, cancer doctor, and surgeon together to decide on the best next step.
Can you cure Urachus cancer?
There is no guaranteed cure for urachus cancer, but some people can be cured if it is found early and removed completely with surgery. If the cancer has spread or comes back, treatment usually aims to control it, slow its growth, and ease symptoms, often with surgery, chemotherapy, and close follow-up.
Non-drug treatment
For many living with urachus cancer, treatment often centers on procedures rather than daily medicines. Surgery is the main non-drug treatment, and supportive care can also help with recovery, comfort, and day-to-day function. Managing this condition often means working with a team that plans care around where the cancer is, whether it has spread, and your overall health.
Surgery is the main treatment for urachus cancer that has not spread widely. It often removes the urachus, the belly button area, and part or all of the bladder tissue connected to the tumor. In some people, nearby lymph nodes are also removed to check for spread.
Many people with urachus cancer can have surgery that removes only the part of the bladder involved by the tumor. This may help preserve normal bladder function while still aiming to remove the cancer fully.
If scans or the operation suggest spread, surgeons may remove nearby lymph nodes at the same time. This can help with staging and may guide what other treatment is needed afterward.
In selected cases, surgery may also be used to remove small areas of cancer that have spread or come back. This is not right for everyone, but it can be considered when the disease is limited and can be removed safely.
Your genes may have an impact on how drugs work for you
For people with urachus cancer, inherited differences in your genes can sometimes change how your body breaks down certain cancer medicines, which may affect side effects or how well treatment works. Still, because this cancer is rare, there are not yet widely used gene-based tests that clearly guide standard treatment for most people living with it. In some cases, doctors may test the tumor itself for changes in the cancer cells to see whether a more targeted treatment or a clinical trial could be a good fit.
Pharmacological treatments
Drug treatment for urachus cancer is usually considered when the cancer has spread, comes back after surgery, or cannot be fully removed. Because this cancer is rare, there is no single standard medicine plan, and doctors often borrow treatments used for bladder or bowel-type gland cancers. Not everyone responds to the same medication in the same way. In practice, treatment is often tailored to the tumor’s features, your overall health, and whether the goal is to shrink the cancer, slow its growth, or ease symptoms.
Fluorouracil, often called 5-FU, is one of the main drugs used in chemotherapy for advanced urachus cancer. It is often paired with leucovorin to help it work better, and it may be combined with oxaliplatin or irinotecan.
Cisplatin and carboplatin are commonly used chemotherapy drugs for urachus cancer, especially in combination plans. These medicines damage cancer cell DNA, but they can also cause side effects such as nausea, fatigue, numbness, or kidney and blood count problems.
Gemcitabine is sometimes used with cisplatin or carboplatin, particularly when doctors choose a bladder-cancer style regimen. For some people living with urachus cancer, this may help control disease for a time, although responses can vary.
Oxaliplatin and irinotecan are often used as part of bowel-cancer type regimens such as FOLFOX or FOLFIRI, usually alongside 5-FU and leucovorin. These combinations may be considered because many urachus tumors behave more like adenocarcinoma than typical bladder cancer.
Genetic influences
After a rare diagnosis, many people with urachus cancer wonder whether it could affect other relatives. It’s natural to ask whether family history plays a role. Based on what is known so far, urachus cancer is not usually thought to be an inherited cancer, and most cases appear to happen sporadically rather than because of a gene change passed down in a family. In many living with urachus cancer, the DNA changes seem to develop in the tumor over time, which means they are different from inherited changes that can be shared by children, brothers, or sisters.
Because urachus cancer is very rare, research on its genetic influences is still limited. Even so, genetic testing for urachus cancer may sometimes be done on the tumor itself to look for changes that could help guide treatment, especially if the cancer has spread or returned. If someone with urachus cancer is diagnosed at a younger age or has a strong family history of several cancers, the care team may also suggest genetic counseling to check for a broader inherited cancer risk.
Is Urachus cancer genetic?
Genetics do not appear to drive most urachus cancer cases strongly. In urachus cancer, inherited risk is not well established, but tumor gene changes can sometimes help guide testing, outlook, or treatment decisions.
Having a genetic risk is not necessarily a diagnosis
Across the general population, genetic variants are common and represent a normal part of human biology. Most do not have a direct effect on health and simply make up part of natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-studied variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When urachus cancer has spread or comes back after surgery, treatment choices are often shaped by genetic testing of the tumor. Because urachus cancer is rare, doctors may look for gene changes such as KRAS, BRAF, HER2, or problems in a DNA repair pathway called mismatch repair, since these findings can sometimes suggest targeted drugs or immunotherapy instead of standard chemotherapy alone. Beyond trial and error, genetics offers another way to choose treatment when the usual options are limited. In some cases, inherited drug-response genes matter too: changes in DPYD can raise the risk of serious side effects from 5-fluorouracil or capecitabine, and changes in UGT1A1 can affect how well irinotecan is tolerated. That means genetic testing for urachus cancer treatment may help your team adjust the dose, choose a different medicine, or watch more closely for side effects. Genetics does not decide treatment by itself, though, and doctors also consider where the cancer is, how fast it is growing, and your overall health.
Interactions with other conditions
Because urachus cancer grows near the bladder, its symptoms can look a lot like more common problems such as urinary tract infections, bladder irritation, or sometimes bladder cancer itself. Someone might notice blood in the urine, pelvic discomfort, or repeated infections and assume it is a routine urinary problem, which can delay the right diagnosis. Doctors call it a comorbidity when two conditions occur together, and this matters because people with urachus cancer may also be dealing with bladder problems, kidney drainage issues, or infections that affect how they feel day to day. If the tumor blocks urine flow, it can raise the risk of infection or strain the kidneys, which may add fatigue, fever, or back pain to the picture. Urachus cancer can also involve the bladder or nearby tissues, so treatment plans often need to take other urinary or abdominal conditions into account. If there are early symptoms of urachus cancer along with another bladder or kidney condition, careful testing is important so one illness is not mistaken for the other.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Urachus cancer?
Symptoms of urachus cancer can look like more common problems such as a bladder infection, bladder cancer, or kidney stones, especially when there is blood in the urine, pain in the lower belly, or trouble peeing. In some people, an infected leftover pocket from before birth in the same area can cause similar pain, swelling, or discharge. If there is a lump or drainage near the belly button, a hernia or a skin infection there can also be mistaken for it.
History
Long before scans and modern lab testing, doctors sometimes encountered unusual tumors near the top of the bladder or behind the belly button and struggled to name them clearly. Many living with urachus cancer today are dealing with a condition that was once easily confused with other bladder, abdominal, or umbilical problems, especially because symptoms such as blood in the urine, mucus in the urine, or ongoing belly pain can overlap with more common conditions.
As anatomy and pathology improved in the 1800s and early 1900s, physicians began to recognize that some of these tumors came from a small structure left over from before birth, called the urachus. Initially understood only through symptoms, later these cancers were linked to that fetal connection between the bladder and the umbilical area. That shift mattered because it helped explain why the disease often behaves differently from the more common kinds of bladder cancer.
For much of the 20th century, urachus cancer remained rare and easy to miss. Some people were diagnosed only after surgery for what looked like a bladder mass, a persistent infection, or a lump near the navel. Not every early description was complete, yet together they helped doctors see recurring patterns, including where these tumors tend to start and how they may spread.
In recent decades, awareness has grown as imaging, pathology, and cancer staging have become more precise. This has made it easier to separate urachus cancer from other cancers in the bladder area and to study which treatments are most helpful. Researchers also learned that many cases are adenocarcinomas, meaning they arise from gland-like cells, which is another way urachus cancer differs from the bladder cancers most people hear about.
Today, the history of urachus cancer still shapes care. Because it is uncommon, many people first hear the name only after tests for early symptoms of urachus cancer, such as blood in the urine or repeated urinary discomfort. Looking back at how the condition was recognized over time helps explain why diagnosis can still take time, and why care is often guided by specialists who are familiar with rare urinary tract cancers.